抗病毒治疗持续时间的临床特征和预测因子 住院患者 性结肠炎 相关的细胞巨血病毒结肠炎,包括生物疗法治疗
1Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Kocaeli University, 41001 İzmit, Turkey.
Viruses
|February 27, 2026
概括
在性结肠炎患者中,细胞巨乳病毒 (CMV) 大肠炎在免疫抑制期间很常见. 组织中较高的CMV病毒载量预测需要更长时间的抗病毒治疗,有助于临床决策.
科学领域:
- 胃肠病学 胃肠病学
- 病毒学 病毒学
- 临床医学 临床医学
背景情况:
- 细胞巨乳病毒 (CMV) 大肠炎经常使性结肠炎 (UC) 管理复杂化,特别是在免疫抑制疗法下.
- 这些患者抗病毒治疗持续时间的预测因素尚未得到充分确立.
研究的目的:
- 为了确定与住院UC患者的CMV大肠炎抗病毒治疗时间相关的因素.
- 为了确定组织CMV聚合酶连锁反应 (PCR) 病毒载量是否可以预测长时间的抗病毒治疗.
主要方法:
- 对52名住院的成人UC患者进行了回顾性队列研究,其中证实了CMV大肠炎.
- 对人口,临床,内镜和实验室数据的分析,按抗病毒治疗持续时间分层 (≤14天vs>14天).
- 组织CMVPCR病毒载量与实验室参数之间的相关性分析;用于预测长期治疗的ROC分析.
主要成果:
- 接受抗病毒治疗超过14天的患者具有较高的组织CMV PCR病毒载荷.
- 组织CMVPCR切断值为162,000 IU/mg预测了长期治疗 (AUC=0.69,敏感性=70.4%,特异性=76.0%).
- 组织CMVPCR病毒载量显示与血清白蛋白水平的负相关性较弱.
结论:
- 组织CMVPCR病毒载量是与CMV大肠炎UC患者抗病毒治疗持续时间相关的重要因素.
- 这种病毒载荷值可能有助于临床医生识别需要延长抗病毒治疗的患者.
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
577
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
577
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.6K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.6K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
658
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
658
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
604
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
604
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
577
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
577
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K